Alpha-adrenoreceptor antagonists

WATSON 152 8 mg Pill - white capsule-shape, 19mm

Generic Name: silodosin

Pill with imprint WATSON 152 8 mg is White, Capsule-shape and has been identified as Rapaflo 8 mg. It is supplied by Allergan, Inc.

Rapaflo is used in the treatment of Benign Prostatic Hyperplasia and belongs to the drug class alpha-adrenoreceptor antagonists. There is no proven risk in humans during pregnancy. Rapaflo 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Rapaflo (Silodosin [ sil-oh-doe-sin ])-WATSON 152 8 mg-8 mg-White-Capsule-shape
Rapaflo (Silodosin [ sil-oh-doe-sin ])-WATSON 152 8 mg-8 mg-White-Capsule-shape
Rapaflo (Silodosin [ sil-oh-doe-sin ])-WATSON 152 8 mg-8 mg-White-Capsule-shape
Rapaflo (Silodosin [ sil-oh-doe-sin ])-WATSON 152 8 mg-8 mg-White-Capsule-shape
Rapaflo (Silodosin [ sil-oh-doe-sin ])-WATSON 152 8 mg-8 mg-White-Capsule-shape

Rapaflo
Generic Name: silodosin [ sil-oh-doe-sin ]
Imprint: WATSON 152 8 mg
Strength: 8 mg
Color: White
Size: 19.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Alpha-adrenoreceptor antagonists
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 52544-0152 (Discontinued)
Inactive Ingredients:
Latest News
Related Drugs